TWD
SUPN icon

True Wealth Design’s Supernus Pharmaceuticals SUPN Stock Holding History

True Wealth Design’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605 Buy
13
+4
+44% +$192 ﹤0.01% 2136
2026
Q1 		$466 Hold
9
– – ﹤0.01% 2083
2025
Q4 		$448 Hold
9
– – ﹤0.01% 1984
2025
Q3 		$431 Hold
9
– – ﹤0.01% 2055
2025
Q2 		$284 Sell
9
-97
-92% -$3.11K ﹤0.01% 1963
2025
Q1 		$3.47K Buy
106
+1
+1% +$35 ﹤0.01% 802
2024
Q4 		$3.8K Buy
105
+8
+8% +$282 ﹤0.01% 589
2024
Q3 		$3.02K Buy
+97
New +$3.03K ﹤0.01% 684

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

True Wealth Design's SUPN Position: Q2 2026 in Review

True Wealth Design increased its Supernus Pharmaceuticals (SUPN) stake by 44% in Q2 2026, buying an estimated $192 and bringing the position to 13 shares worth $605. The position accounts for ﹤0.01% of the portfolio, ranked #2136.

True Wealth Design first reported a position in SUPN in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.8K in Q4 2024. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • True Wealth Design held 13 shares of Supernus Pharmaceuticals worth $605 as of Q2 2026.
  • True Wealth Design bought 4 Supernus Pharmaceuticals shares in Q2 2026, an estimated $192.
  • Supernus Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2136 holding.
  • True Wealth Design first reported a position in Supernus Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • True Wealth Design's Supernus Pharmaceuticals position peaked at $3.8K in Q4 2024.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.